Cory Fiset has a diverse work experience in the field of finance. Cory started their career in 2011 at Freudenberg-NOK as a Financial Analyst before moving on to Vertex Pharmaceuticals in 2012. At Vertex Pharmaceuticals, Cory held multiple roles including Senior Financial Analyst, Manager, and Senior Manager in both Commercial Finance and Corporate Finance. In 2019, they joined Intarcia Therapeutics, Inc. as an Associate Director of Strategic Planning, later becoming the Director of Strategic Planning. Currently, Cory is working at Akebia Therapeutics as the Director of Corporate Finance, and has recently been promoted to the role of Senior Director.
Cory Fiset's education journey began in 2007 when they started attending the UNH Peter T. Paul College of Business and Economics. They pursued a Bachelor of Science degree in Finance & Accounting, completing their studies in 2011. In 2009, Cory briefly studied at the Corvinus University of Budapest, focusing on International Finance. However, it is unknown whether they obtained a degree from this institution.
February, 2022 - present
July, 2020